NCT05072613View on ClinicalTrials.gov

Monitoring Pregnant Women for Antimalarial Drug Resistance

CompletedOBSERVATIONAL
Enrollment

6,833

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
Malaria
Interventions
OTHER

Malaria screening

Participants are screened for malaria and a dried blood spot is collected from malaria positive cases

Trial Locations (1)

Unknown

Kinshasa Medical Oxford Research Unit, Kinsasa

All Listed Sponsors
collaborator

Kinshasa School of Public Health

OTHER

collaborator

Wellcome Sanger Institute

OTHER

lead

University of Oxford

OTHER

NCT05072613 - Monitoring Pregnant Women for Antimalarial Drug Resistance | Biotech Hunter | Biotech Hunter